Silvia Deandrea, Federica Manzoni, Marina Tanious, Andrea Parrini, Marinella Crema, Pietro Perotti, Simona Dalle Carbonare, Giancarlo Magenes, Ennio Cadum, Lorenza Boschetti, Stefano Marguati, Lorella Cecconami, Anna Odone
{"title":"Population-based breast cancer screening in Pavia (northern Italy) in 2016-2018: Key performance indicators and sensitivity estimate.","authors":"Silvia Deandrea, Federica Manzoni, Marina Tanious, Andrea Parrini, Marinella Crema, Pietro Perotti, Simona Dalle Carbonare, Giancarlo Magenes, Ennio Cadum, Lorenza Boschetti, Stefano Marguati, Lorella Cecconami, Anna Odone","doi":"10.23750/abm.v94iS3.14511","DOIUrl":null,"url":null,"abstract":"<p><strong>Background and aim: </strong>This study aims to assess the quality of the population-based breast cancer screening programme in Pavia, northern Italy computing its key performance indicators and estimating its sensitivity for the years 2016-2018.</p><p><strong>Methods: </strong>Invitation and examination coverage, participation rate, recall rate, detection rate and positive predictive values were computed on the basis of data provided yearly to the Italian Ministry of Health. Sensitivity was estimated identifying interval cancers in the local Cancer Registry and computed with the proportional incidence method.</p><p><strong>Results: </strong>In 2016-2018 the adjusted invitation coverage was 90%, and the adjusted participation rate was 62%. Recall rate was 8.4% for first screenings and 3.9% for subsequent ones. The number of screen-detected cases was 268, corresponding to a detection rate of 6.6‰ for first screenings and 4.6‰ for subsequent screenings. The number of interval cancers observed was 110 over the study period; the proportional incidence was 22% for the first interval year and 50% for the second interval. The overall sensitivity of the screening program was 64%.</p><p><strong>Conclusions: </strong>The analysis of performance indicators and sensitivity estimates for the Pavia programme indicates that the programme performance is in line with the quality standards set by the European Union and the Italian reference scientific society (GISMa).</p>","PeriodicalId":35682,"journal":{"name":"Acta Biomedica de l''Ateneo Parmense","volume":"94 S3","pages":"e2023160"},"PeriodicalIF":0.0000,"publicationDate":"2023-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta Biomedica de l''Ateneo Parmense","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23750/abm.v94iS3.14511","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0
Abstract
Background and aim: This study aims to assess the quality of the population-based breast cancer screening programme in Pavia, northern Italy computing its key performance indicators and estimating its sensitivity for the years 2016-2018.
Methods: Invitation and examination coverage, participation rate, recall rate, detection rate and positive predictive values were computed on the basis of data provided yearly to the Italian Ministry of Health. Sensitivity was estimated identifying interval cancers in the local Cancer Registry and computed with the proportional incidence method.
Results: In 2016-2018 the adjusted invitation coverage was 90%, and the adjusted participation rate was 62%. Recall rate was 8.4% for first screenings and 3.9% for subsequent ones. The number of screen-detected cases was 268, corresponding to a detection rate of 6.6‰ for first screenings and 4.6‰ for subsequent screenings. The number of interval cancers observed was 110 over the study period; the proportional incidence was 22% for the first interval year and 50% for the second interval. The overall sensitivity of the screening program was 64%.
Conclusions: The analysis of performance indicators and sensitivity estimates for the Pavia programme indicates that the programme performance is in line with the quality standards set by the European Union and the Italian reference scientific society (GISMa).
期刊介绍:
Acta Bio Medica Atenei Parmensis is the official Journal of the Society of Medicine and Natural Sciences of Parma, and it is one of the few Italian Journals to be included in many excellent scientific data banks (i.e. MEDLINE). Acta Bio Medica was founded in 1887 and its founders and collaborators, Clinicians and Surgeons, entered history. Acta Bio Medica Atenei Parmensis publishes Original Articles, Commentaries, Review Articles, Case Reports of experimental and general Medicine. A section is devoted to a Continuous Medical Education programme in order to help primary care Physicians to improve the quality of care.